The MI Molecular Intelligence Profile Test, available at DNA Labs UAE, represents a cutting-edge diagnostic approach that leverages advanced molecular analysis to uncover detailed insights into an individual's genetic makeup. Priced at 117,000 AED, this comprehensive test is designed to identify genetic predispositions to various health conditions, potential responses to certain medications, and overall genetic health risks. By analyzing an individual's DNA, the MI Molecular Intelligence Profile Test can provide personalized recommendations for lifestyle adjustments, dietary changes, and preventive measures to optimize health and well-being. DNA Labs UAE, known for its state-of-the-art facilities and expert team, ensures a thorough and accurate analysis, making the MI Molecular Intelligence Profile Test a valuable tool for those seeking to understand their genetic profile and take proactive steps towards personalized healthcare.
The MI Molecular Intelligence Tumor Seek Test is an advanced diagnostic tool designed to identify the genetic alterations in a patient's tumor. By analyzing the DNA and RNA of cancer cells, this test provides a comprehensive molecular profile of the tumor, which can guide personalized treatment strategies. It aims to match patients with targeted therapies and clinical trials that are most likely to be effective for their specific cancer type, based on the unique genetic makeup of their tumor.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics and research, the test leverages cutting-edge sequencing technologies to decode the complex biology of cancer. The cost of the MI Molecular Intelligence Tumor Seek Test is 93,600 AED, reflecting the extensive analysis and detailed insights it offers into the molecular drivers of an individual's cancer. This investment can be crucial for patients seeking to optimize their treatment options and improve their outcomes by targeting the root genetic causes of their disease.
The Genome Signature HRD (Homologous Recombination Deficiency) Test is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to evaluate the inability of cancer cells to repair double-stranded DNA breaks. This test plays a crucial role in the field of personalized medicine, especially in the context of cancer treatment, by identifying patients who are likely to benefit from specific therapies, such as PARP inhibitors. The test examines the genome for signatures that indicate a deficiency in homologous recombination, a critical pathway for DNA repair. By doing so, it helps in predicting the responsiveness of certain cancers, including breast, ovarian, and prostate cancers, to specific treatments, thereby allowing for more targeted and effective therapeutic approaches. The cost of the Genome Signature HRD Test at DNA Labs UAE is 54,000 AED, reflecting the sophisticated technology and expertise required to conduct this specialized diagnostic procedure.
The NGS TP53 Mutation Analysis Test, available at DNA Labs UAE for a cost of 42,000 AED, is a sophisticated genetic testing procedure designed to identify mutations in the TP53 gene. This gene plays a crucial role in regulating cell division and preventing the development of tumors, making its analysis vital for understanding individual cancer risks and for the diagnosis of certain genetic disorders, such as Li-Fraumeni syndrome. Utilizing Next-Generation Sequencing (NGS) technology, the test offers a comprehensive examination of the TP53 gene, allowing for the detection of both known and novel mutations with high precision and accuracy. The results from this test can provide essential information for personalized treatment planning, including decisions regarding surveillance, surgery, chemotherapy, or radiation therapy, enhancing the potential for positive patient outcomes. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the NGS TP53 Mutation Analysis Test represents a significant advancement in the field of personalized medicine and genetic diagnostics.
The Oncomine Comprehensive Plus Panel Test is a cutting-edge genetic test designed to provide a comprehensive analysis of cancer-related genes. This test, performed by DNA Labs UAE, is aimed at identifying genetic mutations and alterations in a wide array of genes associated with different types of cancer. With a cost of 39,000 AED, it offers an extensive assessment that helps in guiding personalized treatment plans for cancer patients.
The test utilizes next-generation sequencing (NGS) technology to examine a broad panel of genes for mutations that could influence a patient's response to certain cancer therapies, making it an invaluable tool in the realm of precision medicine. By pinpointing specific genetic mutations, healthcare providers can tailor treatments to the individual's genetic profile, potentially improving outcomes and minimizing unnecessary side effects.
The Oncomine Comprehensive Plus Panel Test is particularly useful for patients with advanced or difficult-to-treat cancers, where conventional treatment options may have been exhausted or are deemed less effective. The insights gained from this test can lead to the identification of targeted therapies and clinical trial opportunities that are most likely to benefit the patient based on their unique genetic makeup.
DNA Labs UAE, known for its state-of-the-art facilities and expertise in genetic testing, ensures that the test is conducted with the highest standards of accuracy and reliability. Their team of specialized geneticists and clinicians work closely with patients and healthcare providers to interpret the results and integrate them into the patient's care plan.
In summary, the Oncomine Comprehensive Plus Panel Test offered by DNA Labs UAE is a significant advancement in cancer care, providing a deeper understanding of the genetic underpinnings of an individual's cancer and opening up personalized treatment avenues. With its comprehensive approach and the high cost reflective of its extensive analysis, it represents a crucial step forward in the fight against cancer.
The Oncopro Liquid Biopsy Test is a cutting-edge diagnostic tool offered by DNA Labs UAE, designed to detect and monitor various types of cancers through a non-invasive method. This innovative test requires only a blood sample from the patient, making it a less intrusive option compared to traditional biopsy methods that require tissue samples. The liquid biopsy technique focuses on analyzing circulating tumor DNA (ctDNA) present in the blood, which sheds from the tumor, allowing for the identification of genetic mutations and alterations associated with cancer.
With a cost of 38,610 AED, the Oncopro Liquid Biopsy Test represents a significant investment in personal health care, offering a valuable resource for early detection, treatment planning, and monitoring of cancer progression or response to treatment. The test is particularly beneficial for patients who are unable to undergo conventional biopsy procedures due to health constraints or for cancers that are difficult to access. By providing detailed insights into the molecular profile of a patient's cancer, the Oncopro Liquid Biopsy Test enables personalized treatment strategies, potentially improving outcomes and quality of life for cancer patients.
DNA Labs UAE, as the provider of this test, underscores its commitment to leveraging advanced genetic testing technologies to support cancer care. The test is part of a broader movement towards precision medicine, where treatments can be tailored to the individual characteristics of each patient's disease, offering a more targeted and effective approach to cancer treatment.
WE DO NOT GIVE ANY MEDICAL ADVICE SERVICE DESCRIPTION • This website is for information purpose only and NOT any kind of advice and all information may or may not be suitable for you. All contents on this website are neither medical advice nor meant to substitute you consulting your doctor. DNA Labs UAE partners
PRIVACY POLICY 1.INFORMATION GATHERED BY DNALABSUAE.COM 1.1. This is Dnalabsuae.com’s (“Dnalabsuae.com”) online privacy policy (“policy”). This policy applies only to activities Dnalabsuae.com engages in on its website and does not apply to Dnalabsuae.com’s activities that are “offline” or unrelated to the website. 1.2. Dnalabsuae.com collects certain anonymous data regarding the usage of
